International Journal of Medical Sciences

Impact factor

15 December 2018

ISSN 1449-1907 News feeds of published articles

Manuscript login | Account

open access Global reach, higher impact

Journal of Genomics in PubMed Central. Submit manuscript now...


Journal of Cancer

International Journal of Biological Sciences

Journal of Genomics



Journal of Biomedicine

PubMed Central Indexed in Journal Impact Factor

Int J Med Sci 2011; 8(1):16-29. doi:10.7150/ijms.8.16

Research Paper

A Novel Population of Mesenchymal Progenitors with Hematopoietic Potential Originated from CD14- Peripheral Blood Mononuclear Cells

Gang Hu1,2,* , Peng Liu2,3,4,*, Jie Feng1, Yan Jin2,3

1. Department of Dermatology, Second Hospital of Xi'an Jiaotong University, Xi'an, 710004, China
2. Research and Development Center for Tissue Engineering, Fourth Military Medical University, Xi'an, 710032, China
3. Department of Oral Histology and Pathology, School of Stomatology, Fourth Military Medical University, Xi'an, 710032, China
4. Department of Stomatology, No.201 Military Hospital of PLA, Liaoyang, 111000, China
* These authors contribute equally to the manuscript


Hemopoietic system derived progenitor cells with mesenchymal features have been identified including CD14+ monocyte-derived progenitors. However, it is unclear whether there are mesenchyme derived progenitors with hematopoietic potential. Herein, we identified a novel CD14- cell-derived population with both mesenchymal and hematopoietic features in rat peripheral blood, and this cell population is different from the CD14+ monocyte-derived progenitors but designated peripheral blood multipotential mesenchymal progenitors (PBMMPs). Phenotype analysis demonstrated expression of mesenchymal markers in PBMMPs including BMPRs, Endoglin/CD105, Fibronectin (Fn), Vimentin (Vim), Collagen (Col) I/II/III along with hematopoietic marker CD34. CD14+ cell-derived population shared the same characteristics with CFs. In mixed culture of CD14+ and CD14- cells, PBMMPs were a predominant component and expressed CD29high, CD73high, CD34high, CD45low and CD90. Except for the value of mixed T lymphocytes and CD14+ cell-derived population, hematopoietic characters of cultured PBMMPs were indicated by CD14-/CD34+/CD45-/CD90+. The mesenchymal origin was further confirmed by comparing PBMMPs with bone marrow stromal cells. Finally, we transplanted PBMMPs into a skin wound model, and results showed the specific potential of PBMMPs in not only extracellular matrix secretion but epidermal regeneration. This study provides evidence that peripheral blood contains common hematopoietic-mesenchymal progenitors from both hematopoietic and mesenchymal lineages, and CD34+ mesenchymal progenitors are a possible alternative source of epidermal cells in wound healing.

Keywords: Peripheral blood stem cells, Mesenchymal stem cells, Hemopoietic stem cells, Stem cell plasticity, Common progenitor, Wound healing

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See for full terms and conditions.
How to cite this article:
Hu G, Liu P, Feng J, Jin Y. A Novel Population of Mesenchymal Progenitors with Hematopoietic Potential Originated from CD14- Peripheral Blood Mononuclear Cells. Int J Med Sci 2011; 8(1):16-29. doi:10.7150/ijms.8.16. Available from